Acetic acid dressings used to treat pseudomonas colonised burn wounds: A UK national survey.


Journal

Burns : journal of the International Society for Burn Injuries
ISSN: 1879-1409
Titre abrégé: Burns
Pays: Netherlands
ID NLM: 8913178

Informations de publication

Date de publication:
09 2022
Historique:
received: 09 04 2021
revised: 15 07 2021
accepted: 20 07 2021
pubmed: 5 12 2021
medline: 9 9 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

Wound infection following burn injury can be clinically challenging to manage. Its presence in a thermally compromised patient can detrimentally affect the ability of the wound to heal leading not only to wound progression but ultimately contribute to a large part of the economic health burden expenditure in the National Health Service. Despite meticulous wound care and infection control measures the colonisation of burn wounds by bacterial pathogens has and continues to be the case. There has been a growing interest in the use of antimicrobial applications when managing localised burn wound infections due to a constantly increasing number of antibiotic-resistant organisms. To survey which antimicrobial dressings are currently being used across UK burns services when managing localised pseudomonas wound infections. We conducted a nationwide telephone survey of UK burns services during October 2019 to determine which topical antimicrobial agent was used to treat local pseudomonas burn wound infections. Six burns services (31.6%) used acetic acid-soaked dressings, one of which alternates acetic acid with sodium hypochlorite solution. Silver-based dressings were also used by six burns services (31.6%) - again, one department alternates silver-based dressings with sodium hypochlorite solution. Betadine-soaked, gauze-based dressings were used across five burns services (26.3%) and the remaining two burns services (10.5%) used sodium hypochlorite solution and non-medicated dressings respectively. We identified a significant difference in the UK burns services' approach to pseudomonas burn wound infections. Our literature review demonstrates that a daily dressing regime of 2.5-3% acetic acid is a well-tolerated treatment regime in burn patients and that it is in use in UK burns services. There are no current randomised controlled trials that evaluate the usage of acetic acid. The variation in usage suggests that there is scope for further study in order to develop evidence to generate a UK wide approach based on national standardised guidelines.

Identifiants

pubmed: 34862089
pii: S0305-4179(21)00191-1
doi: 10.1016/j.burns.2021.07.011
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Silver 3M4G523W1G
Sodium Hypochlorite DY38VHM5OD
Acetic Acid Q40Q9N063P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1364-1367

Informations de copyright

Copyright © 2021 Elsevier Ltd and ISBI. All rights reserved.

Auteurs

Shahd Nour (S)

Department of Burns and Plastic Surgery, Southmead Hospital, North Bristol NHS Foundation Trust, BS10 5BN, United Kingdom. Electronic address: shahd.nour@nhs.net.

Gavin Reid (G)

Department of Burns and Plastic Surgery, Southmead Hospital, North Bristol NHS Foundation Trust, BS10 5BN, United Kingdom.

Kugili Sathanantham (K)

Department of Dermatology, Royal United Hospitals Bath, Combe Park, Bath BA1 3NG, United Kingdom.

Ian Mackie (I)

Department of Burns and Plastic Surgery, Southmead Hospital, North Bristol NHS Foundation Trust, BS10 5BN, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH